The nature of clinical trials in nephrology (Q46662827)

24 December 2017

editorial

0 references

title

The nature of clinical trials in nephrology (English)

1 reference

24 December 2017

author name string

Bolton WK

series ordinal

1

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 November 1992

1 reference

24 December 2017

published in

Kidney International

1 reference

24 December 2017

volume

42

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

1061-1069

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.1992.388

exact match

0 references

cites work

Origins of nephrology: Hippocrates, the father of clinical nephrology

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Of mice but not men. Problems of the randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Double standards, scientific methods, and epidemiologic research

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

The interpretation of epidemiologic studies

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Can meta-analyses be trusted?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Methylprednisolone therapy for acute crescentic rapidly progressive glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on life-table analysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Diffuse and focal proliferative lupus nephritis: treatment approaches and results

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Treatment of proteinuric idiopathic glomerulonephritides in adults: a retrospective survey

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Prognosis and treatment of membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Diabetic nephropathy: hemodynamic basis and implications for disease management

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

The modification of diet in renal disease study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Effect of Cyclophosphamide upon the Immune Response in Wegener's Granulomatosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Genetic factors in focal segmental glomerulosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Of rats and men: the need for more convincing clinical studies on progression of renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Role of interstitial infiltration of leukocytes in glomerular diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

The relationship of infiltrating renal leucocytes to disease activity in lupus and cryoglobulinaemic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Lipid abnormalities in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Strong association between IgA nephropathy and HLA-DR4 antigen

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Strong association of idiopathic membranous nephropathy with HLA-DR2 and MT1 in Japanese

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Major-histocompatibility-complex extended haplotypes in membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

A retrospective analysis of the natural history of primary IgA nephropathy worldwide

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Membranous Nephropathy: Its Relative Benignity in Women

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

T cell recognition as the target for immune intervention in autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

The contribution of non-MHC genes to susceptibility to autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Proteinuria and progression in human glomerular diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Progression of chronic renal failure in man.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Morbidity of systemic lupus erythematosus: role of race and socioeconomic status

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Measurement of renal function in chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Dietary protein restriction in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

The epidemiologic evidence for a relationship between social support and health

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Intervention strategies to improve compliance with medical regimens by ambulatory hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.388

7 January 2021

Identifiers

DOI

10.1038/KI.1992.388

1 reference

24 December 2017

PubMed ID

1453593

1 reference

24 December 2017